Your browser doesn't support javascript.
loading
Phase I trial of GBS-01 for advanced pancreatic cancer refractory to gemcitabine.
Ikeda, Masafumi; Sato, Akihiro; Mochizuki, Nobuo; Toyosaki, Kayo; Miyoshi, Chika; Fujioka, Rumi; Mitsunaga, Shuichi; Ohno, Izumi; Hashimoto, Yusuke; Takahashi, Hideaki; Hasegawa, Hiromi; Nomura, Shogo; Takahashi, Ryuji; Yomoda, Satoshi; Tsuchihara, Katsuya; Kishino, Satoshi; Esumi, Hiroyasu.
Afiliação
  • Ikeda M; Department of Hepatobiliary and Pancreatic Oncology, National Cancer Center Hospital East, Kashiwa, Japan.
  • Sato A; Clinical Trial Section, National Cancer Center Hospital East, Kashiwa, Japan.
  • Mochizuki N; Department of Medication Use Analysis and Clinical Research, Meiji Pharmaceutical University, Tokyo, Japan.
  • Toyosaki K; Clinical Trial Section, National Cancer Center Hospital East, Kashiwa, Japan.
  • Miyoshi C; Division of Translational Research, Exploratory Oncology and Clinical Trial Center, National Cancer Center, Kashiwa, Japan.
  • Fujioka R; Division of Translational Research, Exploratory Oncology and Clinical Trial Center, National Cancer Center, Kashiwa, Japan.
  • Mitsunaga S; Department of Hepatobiliary and Pancreatic Oncology, National Cancer Center Hospital East, Kashiwa, Japan.
  • Ohno I; Department of Hepatobiliary and Pancreatic Oncology, National Cancer Center Hospital East, Kashiwa, Japan.
  • Hashimoto Y; Department of Hepatobiliary and Pancreatic Oncology, National Cancer Center Hospital East, Kashiwa, Japan.
  • Takahashi H; Department of Hepatobiliary and Pancreatic Oncology, National Cancer Center Hospital East, Kashiwa, Japan.
  • Hasegawa H; Clinical Trial Section, National Cancer Center Hospital East, Kashiwa, Japan.
  • Nomura S; Biostatistics Division, Center for Research Administration and Support, National Cancer Center, Kashiwa, Japan.
  • Takahashi R; Kampo Research Laboratory, Kracie Pharma, Ltd., Toyama, Japan.
  • Yomoda S; Kampo Research Laboratory, Kracie Pharma, Ltd., Toyama, Japan.
  • Tsuchihara K; Division of Translational Research, Exploratory Oncology and Clinical Trial Center, National Cancer Center, Kashiwa, Japan.
  • Kishino S; Department of Medication Use Analysis and Clinical Research, Meiji Pharmaceutical University, Tokyo, Japan.
  • Esumi H; Division of Translational Research, Exploratory Oncology and Clinical Trial Center, National Cancer Center, Kashiwa, Japan.
Cancer Sci ; 107(12): 1818-1824, 2016 Dec.
Article em En | MEDLINE | ID: mdl-27685612
Assuntos
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Neoplasias Pancreáticas / Resistencia a Medicamentos Antineoplásicos / Antineoplásicos Fitogênicos Limite: Adult / Aged / Female / Humans / Male / Middle aged Idioma: En Revista: Cancer Sci Ano de publicação: 2016 Tipo de documento: Article País de afiliação: Japão
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Neoplasias Pancreáticas / Resistencia a Medicamentos Antineoplásicos / Antineoplásicos Fitogênicos Limite: Adult / Aged / Female / Humans / Male / Middle aged Idioma: En Revista: Cancer Sci Ano de publicação: 2016 Tipo de documento: Article País de afiliação: Japão